BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10435575)

  • 1. ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer.
    Nikolajczyk BS; Sanchez JA; Sen R
    Immunity; 1999 Jul; 11(1):11-20. PubMed ID: 10435575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1 as a chromatin accessibility factor for immunoglobulin genes.
    Marecki S; McCarthy KM; Nikolajczyk BS
    Mol Immunol; 2004 Jan; 40(10):723-31. PubMed ID: 14644098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer.
    Rao E; Dang W; Tian G; Sen R
    J Biol Chem; 1997 Mar; 272(10):6722-32. PubMed ID: 9045705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
    Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
    Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1 co-activates transcription in B cells through indirect association with DNA.
    McCarthy KM; McDevit D; Andreucci A; Reeves R; Nikolajczyk BS
    J Biol Chem; 2003 Oct; 278(43):42106-14. PubMed ID: 12907668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer.
    Dang W; Sun XH; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1477-88. PubMed ID: 9488464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.
    Erman B; Sen R
    EMBO J; 1996 Sep; 15(17):4665-75. PubMed ID: 8887557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.
    McDevit DC; Perkins L; Atchison ML; Nikolajczyk BS
    J Immunol; 2005 Mar; 174(5):2834-42. PubMed ID: 15728493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.
    Erman B; Cortes M; Nikolajczyk BS; Speck NA; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1322-30. PubMed ID: 9488447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication.
    Ariizumi K; Wang Z; Tucker PW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3695-9. PubMed ID: 8475117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    Sepulveda MA; Emelyanov AV; Birshtein BK
    J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise alignment of sites required for mu enhancer activation in B cells.
    Nikolajczyk BS; Nelsen B; Sen R
    Mol Cell Biol; 1996 Aug; 16(8):4544-54. PubMed ID: 8754855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of Imu-Cmu intron by NeoR gene alters Imu germ-line expression but has no effect on V(D)J recombination.
    Haddad D; Dougier HL; Laviolette N; Puget N; Khamlichi AA
    Mol Immunol; 2010 Feb; 47(5):961-71. PubMed ID: 20036775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell development arrest upon insertion of a neo gene between JH and Emu: promoter competition results in transcriptional silencing of germline JH and complete VDJ rearrangements.
    Delpy L; Decourt C; Le Bert M; Cogné M
    J Immunol; 2002 Dec; 169(12):6875-82. PubMed ID: 12471120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the IgH intronic enhancer E mu in enforcing allelic exclusion.
    Li F; Eckhardt LA
    J Exp Med; 2009 Jan; 206(1):153-67. PubMed ID: 19114667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spi-C has opposing effects to PU.1 on gene expression in progenitor B cells.
    Schweitzer BL; Huang KJ; Kamath MB; Emelyanov AV; Birshtein BK; DeKoter RP
    J Immunol; 2006 Aug; 177(4):2195-207. PubMed ID: 16887979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins.
    Tian G; Erman B; Ishii H; Gangopadhyay SS; Sen R
    Mol Cell Biol; 1999 Apr; 19(4):2946-57. PubMed ID: 10082562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a candidate regulatory element within the 5' flanking region of the mouse Igh locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A.
    Pawlitzky I; Angeles CV; Siegel AM; Stanton ML; Riblet R; Brodeur PH
    J Immunol; 2006 Jun; 176(11):6839-51. PubMed ID: 16709844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
    Hodawadekar S; Park K; Farrar MA; Atchison ML
    J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.